Nachrichten zur Abbvie Inc. Aktie

AbbVie Appears Ready To Move Higher

…

This Company Just Initiated a Quarterly Dividend: Time to Buy?

Biotech giant Renegeron Pharmaceuticals (NASDAQ: REGN) reported its fourth-quarter and full-year 2024 earnings on Feb. 4. The companys results were…

Want Decades of Passive Income? Buy This ETF and Hold It Forever.

Who doesnt want passive income? Even Warren Buffett has extolled it, reportedly saying, "If you dont find a way to…

AbbVie: An Undervalued Dividend Aristocrat

…

AbbVie Aktie: AbbWarten

Wien (www.aktiencheck.de) - AbbVie-Aktienanalyse von der Raiffeisen Bank International AG: Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI), stuft in…

3 Fabulous Dividend Stocks to Buy in February

February is the shortest month, but that doesnt mean income investors dont have much time to find great stocks. Three…

3 Dividend Stocks to Double Up on Right Now

Whats better than a good thing? More of a good thing. Income investors can find plenty of "good things" in the…

These 2 Dividend Stocks Are Absolute Bargains Right Now

Dividend stocks are great for many reasons, not least because any company that can sustain growing payouts for a long…

Worried About a Stock Market Crash? Park Your Money in These 2 High-Yielding ETFs for Safety.

Investing in the stock market may not seem like a great idea these days given how expensive many stocks are…

The Zacks Analyst Blog Walmart, Visa, AbbVie and AstroNova

Walmart, Visa, AbbVie and AstroNova are included in this Analyst Blog.…

Earnings Season Scorecard and Fresh Research Reports for Walmart, Visa & AbbVie

A real-time update on the Q4 earnings season is part of todays Research Daily, in addition to fresh reports on…

3 Top AI-Powered Biotech Stocks to Buy in February

Artificial intelligence (AI) is transforming various industries as a major investing theme in 2025. The technologys ability to automate complex…

AbbVie Aktie: Kursziel angehoben

St. Petersburg (www.aktiencheck.de) - Rating-Update: Gary Nachman, Analyst von Raymond James, hat das Kursziel für die Aktie von AbbVie Inc. (ISIN:…

AbbVie Rises 8% Since Q4 Earnings: Buy, Hold or Sell the Stock?

Those who own ABBV stock may stay invested as the company has faced its biggest challenge quite well and looks…

AbbVie Aktie: Neues Kursziel

Toronto (www.aktiencheck.de) - Rating-Update: Evan Seigerman, Analyst von BMO Capital Markets, bestätigt das "outperform"-Votum für die Aktie von AbbVie Inc. (ISIN:…

AbbVie Aktie: Kursziel erhöht

Charlotte, NC (www.aktiencheck.de) - Rating-Update: Die Analysten von Truist haben das Kursziel für die Aktie von AbbVie Inc. (ISIN: US00287Y1091, WKN:…

Analysts reset AbbVie stock price target after earnings

Here’s what could be next for the biopharma stock.…

AbbVies SWOT analysis: stock outlook strong despite humira loss By Investing.com

AbbVies SWOT analysis: stock outlook strong despite humira loss…

Idexx Stock, AbbVie, and Molina Buck Downward Tariff Trend. These Are Today’s Top S&P 500 Performers.

…

Finanzstarker Jahresabschluss: AbbVie übertrifft Erwartungen

AbbVie ist ein global tätiges biopharmazeutisches Unternehmen, das sich auf die Erforschung und Entwicklung von Medikamenten in Bereichen wie Immunologie,…

Notable Healthcare headlines for the week: Moderna, AbbVie, Thermo Fisher, J&J in focus

…

Want $1 Million in Retirement? 2 Stocks to Buy Now and Hold for Decades.

Many people set a goal to save $1 million for retirement. This amount may or may not be sufficient in…

Earnings call transcript: AbbVie Q4 2024 beats expectations, shares rise By Investing.com

Earnings call transcript: AbbVie Q4 2024 beats expectations, shares rise…

AbbVie Q4 Earnings: Strong Revenue Results, Ambitious Forecasts - A Buy With Caveats

…

AbbVie (ABBV) Q4 2024 Earnings Call Transcript

ABBV earnings call for the period ending December 31, 2024.…

AbbVie Beats on Q4 Earnings & Sales, Raises Sales View for Key Drugs

ABBVs fourth-quarter earnings and sales beat estimates. Management raises the 2027 forecast for newer immunology drugs to more than $31…

Why AbbVie Stock Is Jumping Today

Shares of AbbVie (NYSE: ABBV) were jumping 7.1% higher as of 11:10 a.m. ET on Friday after rising as much…

Top Stock Movers Now: Apple, AbbVie, Deckers Outdoor, and More

U.S. equities were mostly higher at midday on positive tech earnings news and a report showing December inflation came in…

AbbVie Aktie: Pharma-Riese trotzt Humira-Einbruch - Skyrizi und Rinvoq treiben Wachstum - Umsatzrekorde ab 2025 erwartet

Kulmbach (www.aktiencheck.de) - AbbVie-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt die Aktie von AbbVie Inc. (ISIN: US00287Y1091,…

AbbVie: Zahlen überraschen – Aktie gibt Gas

Der amerikanische Pharma-Riese AbbVie hat am Freitag die Zahlen für das vierte Quartal 2024 respektive vergangene Geschäftsjahr vorgelegt. Sowohl Umsatz…

AbbVie: Zahlen überraschen – Aktie gibt Gas

Der amerikanische Pharma-Riese AbbVie hat am Freitag die Zahlen für das vierte Quartal 2024 respektive vergangene Geschäftsjahr vorgelegt. Sowohl Umsatz…

Apple, Exxon Mobil, AbbVie rise premarket; Chevron, Colgate-Palmolive fall By Investing.com

Apple, Exxon Mobil, AbbVie rise premarket; Chevron, Colgate-Palmolive fall…

AbbVie stock rises on solid annual profit guidance, Q4 beat By Investing.com

AbbVie stock rises on solid annual profit guidance, Q4 beat…

AbbVie forecasts 2025 profit above estimates, driven by newer immunology drugs

AbbVie forecast 2025 profit above estimates on Friday, as strong sales of its newer immunology drugs Skyrizi and Rinvoq make…

AbbVie shares rise as new drug sales offset Humira decline in Q4

Abbvie Inc (NYSE:ABBV) shares surged after the company posted a positive financial report for the fourth quarter, with sales growth of…

AbbVie Beats on Q4 Earnings & Sales, Raises Sales View for Key Drugs

ABBVs fourth-quarter earnings and sales beat estimates. Management raises the 2027 forecast for newer immunology drugs to more than $31…

I Own 4 High-Yield Dividend Stocks. Heres Why I Own Each One.

When paired with dividend reinvestment, high-yield dividend stocks have demonstrated remarkable outperformance compared to the S&P 500 over holding periods…

AbbVie Q4 Earnings Loom: Buy or Sell ABBV Stock Ahead of Results?

Investors focus will likely be on the sales performance of ABBVs blockbuster immunology drugs, Rinvoq and Skyrizi, when it reports…

Why AbbVie Stock Popped While the Market Flopped on Monday

Monday was a grim day for a great many stocks, but luckily for its investors, AbbVie (NYSE: ABBV) wasnt one…

AbbVie: Q4 2024 Earnings Preview And Update On Emraclidine

…

Is AbbVie Stock a Buy?

Although AbbVie has lost patent exclusivity for its flagship drug, Humira, the company may soon be bigger and better.…

AbbVie Inks a Deal With Neomorph for Molecular Glue Degraders

Per the terms of the deal, AbbVie will use Neomorphs proprietary platform to develop novel drugs targeting oncology and immunology…

Got $1,500? 3 Healthcare Stocks to Buy and Hold Forever

Many products sold by companies arent must-have items. However, healthcare is a necessity. And the healthcare sector is poised to…

Got $500? 2 Pharmaceutical Stocks to Buy and Hold Forever

Youve probably heard this before: Pharmaceutical stocks can bring an element of safety to your portfolio. Why is this the…

This Vanguard ETF Has 23% of Its Portfolio Invested in Tech Stocks, but It Can Still Help You Generate Decades of Passive Income

The technology sector has crushed the S&P 500 over the past three, five, and 10 years as leading tech stocks…

dpa-AFX ProFeed